Enanta Pharmaceuticals
ENTA
#7695
Rank
ยฃ0.32 B
Marketcap
ยฃ11.33
Share price
2.30%
Change (1 day)
102.14%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -ยฃ57.95 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are ยฃ65.32 Million. In 2024 the company made an earning of -ยฃ72.73 Million, an increase over its 2023 earnings that were of -ยฃ95.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ57.95 Million-20.32%
2024 -ยฃ72.73 Million-23.87%
2023 -ยฃ95.53 Million4.39%
2022 -ยฃ91.51 Million-4.4%
2021 -ยฃ95.73 Million91.12%
2020 -ยฃ50.09 Million-407.13%
2019 ยฃ16.3 M-78.63%
2018 ยฃ76.32 M117.97%
2017 ยฃ35.01 M-574.65%
2016 -ยฃ7.38 Million-110.83%
2015 ยฃ68.13 M-4.5%
2014 ยฃ71.34 M-638.53%
2013 -ยฃ13.25 Million-137.98%
2012 ยฃ34.87 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.47 B-34,342.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.83 B-20,904.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
ยฃ4.94 B-8,795.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ3.79 B-6,771.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.85 B-17,435.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ7.19 B-12,749.60%๐Ÿ‡บ๐Ÿ‡ธ USA